Abstract
Case report: A 28 year-old male attended our Emergency Department with a traumatic choroidal rupture and macular haemorrhage. After pneumatic displacement of the haemorrhage with C 3F 8 and tissue plasminogen activator, the haemorrhage was reabsorbed and visual acuity (VA) improved. Three months later the patient presented with decreased VA and a juxtafoveal choroidal neovascularisation (CNV) that was treated with intravitreal bevacizumab. One year after a single bevacizumab injection the CNV remained inactive, with a final VA of 0.5. Discussion: Intravitreal bevacizumab injection is a new and effective treatment for traumatic CNV. In our patient, in contrast to other aetiologies, the CNV needed no more than one Avastin ® injection to be inactivated, after one year of follow-up.
| Original language | Spanish |
|---|---|
| Pages (from-to) | 380-383 |
| Number of pages | 4 |
| Journal | Archivos de la Sociedad Espanola de Oftalmologia |
| Volume | 86 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - Nov 2011 |
Fingerprint
Keywords
- Bevacizumab
- Choroidal neovascularisation
- Choroidal rupture
- Ocular traumatism
- Pneumatic displacement
- Recombinant tissue plasminogen activator (rTPA)
- Submacular haemorrhage
ASJC Scopus subject areas
- Ophthalmology
Cite this
Bevacizumab intravítreo en el tratamiento de la neovascularización subretiniana secundaria a rotura coroidea. / Valldeperas, X.; Bonilla, R.; Romano, M. R.; De La Cámara, J.
In: Archivos de la Sociedad Espanola de Oftalmologia, Vol. 86, No. 11, 11.2011, p. 380-383.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Bevacizumab intravítreo en el tratamiento de la neovascularización subretiniana secundaria a rotura coroidea
AU - Valldeperas, X.
AU - Bonilla, R.
AU - Romano, M. R.
AU - De La Cámara, J.
PY - 2011/11
Y1 - 2011/11
N2 - Case report: A 28 year-old male attended our Emergency Department with a traumatic choroidal rupture and macular haemorrhage. After pneumatic displacement of the haemorrhage with C 3F 8 and tissue plasminogen activator, the haemorrhage was reabsorbed and visual acuity (VA) improved. Three months later the patient presented with decreased VA and a juxtafoveal choroidal neovascularisation (CNV) that was treated with intravitreal bevacizumab. One year after a single bevacizumab injection the CNV remained inactive, with a final VA of 0.5. Discussion: Intravitreal bevacizumab injection is a new and effective treatment for traumatic CNV. In our patient, in contrast to other aetiologies, the CNV needed no more than one Avastin ® injection to be inactivated, after one year of follow-up.
AB - Case report: A 28 year-old male attended our Emergency Department with a traumatic choroidal rupture and macular haemorrhage. After pneumatic displacement of the haemorrhage with C 3F 8 and tissue plasminogen activator, the haemorrhage was reabsorbed and visual acuity (VA) improved. Three months later the patient presented with decreased VA and a juxtafoveal choroidal neovascularisation (CNV) that was treated with intravitreal bevacizumab. One year after a single bevacizumab injection the CNV remained inactive, with a final VA of 0.5. Discussion: Intravitreal bevacizumab injection is a new and effective treatment for traumatic CNV. In our patient, in contrast to other aetiologies, the CNV needed no more than one Avastin ® injection to be inactivated, after one year of follow-up.
KW - Bevacizumab
KW - Choroidal neovascularisation
KW - Choroidal rupture
KW - Ocular traumatism
KW - Pneumatic displacement
KW - Recombinant tissue plasminogen activator (rTPA)
KW - Submacular haemorrhage
UR - http://www.scopus.com/inward/record.url?scp=80255136150&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80255136150&partnerID=8YFLogxK
U2 - 10.1016/j.oftal.2011.05.019
DO - 10.1016/j.oftal.2011.05.019
M3 - Articolo
VL - 86
SP - 380
EP - 383
JO - Archivos de la Sociedad Espanola de Oftalmologia
JF - Archivos de la Sociedad Espanola de Oftalmologia
SN - 0365-6691
IS - 11
ER -